Harrow (HROW) Cost of Revenue (2014 - 2026)
Harrow (HROW) posted quarterly Cost of Revenue of $17.2 million for Q1 2026, up 10.53% year-over-year from $15.5 million in Q1 2025, and down 7.09% quarter-over-quarter from $18.5 million in Q4 2025.
Harrow (HROW) Cost of Revenue (2014 - 2026) Analysis & Trends
Harrow's Cost of Revenue history runs 13 years deep, the most recent figure standing at $17.2 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 10.53% year-over-year to $17.2 million; the TTM figure through Mar 2026 stood at $69.6 million (up 28.32% YoY), while the FY2025 annual figure was $67.9 million, up 37.95% from the prior year.
- Cost of Revenue for Q1 2026 stood at $17.2 million, down from $18.5 million in the prior quarter.
- The five-year high for Cost of Revenue was $18.5 million in Q4 2025, with the low at $6.0 million in Q1 2022.
- The 5-year median for Cost of Revenue is $11.3 million (2023), against an average of $11.7 million.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue surged 83.33% in 2023, then advanced 10.53% in 2026.
- Harrow's Cost of Revenue stood at $6.2 million in 2022, then soared by 83.33% to $11.3 million in 2023, then gained by 25.07% to $14.1 million in 2024, then surged by 30.65% to $18.5 million in 2025, then dropped by 7.09% to $17.2 million in 2026.
- Business Quant data shows HROW's Cost of Revenue at $17.2 million in Q1 2026, $18.5 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Harrow | 1.58 Bn | 1.50 Bn | 50.36 Mn | 20.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.30 Mn |
| Jun 30, 2026 | 20.30 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 15.52 Mn |
| Mar 31, 2025 | 15.52 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Sep 30, 2024 | 12.02 Mn |
| Sep 30, 2024 | 12.02 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 10.55 Mn |
| Mar 31, 2024 | 10.55 Mn |